Explore more publications!

Press Releases

Head-On Train Crash in Denmark Injures Multiple People, Some Critically

Head-On Train Crash in Denmark Injures Multiple People, Some Critically

Several Wounded in Denmark Head-On Train Crash

Several Wounded in Denmark Head-On Train Crash

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
WHO: AI Adoption Spreads Rapidly Across EU Healthcare

WHO: AI Adoption Spreads Rapidly Across EU Healthcare

Focus on French HealthTech’s ecosystem : Panorama France HealthTech 2026 ‘s review: a mature, innovative and resilient sector facing a more demanding environment
Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq
New Research Shows Shared Roots of Major Degenerative Diseases
Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Health Experts Highlight 7 Reasons Seniors Should Stay Active
Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine
BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026
Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe
Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers
Digital Health Monitoring Devices Market Size to Reach USD 35.12B by 2035 from USD 7.40B in 2026 (CAGR 18.90%)
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
Denmark Launches Lawsuit Against Meta Over Child Mental Health Risks

Denmark Launches Lawsuit Against Meta Over Child Mental Health Risks

Clinical Advancements in Gene Therapy for Neurological Diseases Market Outlook 2026–2035
Ascendis Pharma to List Ordinary Shares Directly on Nasdaq
ESO Acquires d2i, Accelerating Emergency Intelligence to Drive Performance and Improve Outcomes across Fire, EMS and Health Systems

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions